Recommending defunct therapies is a safety risk for hemophilia
- PMID: 39949022
- PMCID: PMC11925253
- DOI: 10.2450/BloodTransfus.982
Recommending defunct therapies is a safety risk for hemophilia
References
-
- World Federation of Hemophilia. Commentary on A.11 Cryoprecipitate (pathogen-reduced) for bleeding disorders: EML and EMLc. [Accessed on 5/11/2024]. Available at: https://www.who.int/groups/expert-committee-on-selection-and-use-of-esse....
Publication types
LinkOut - more resources
Full Text Sources